205 related articles for article (PubMed ID: 29877921)
21. Immunohistochemistry, fluorescence in situ hybridization, and reverse transcription-polymerase chain reaction for the detection of anaplastic lymphoma kinase gene rearrangements in patients with non-small cell lung cancer: potential advantages and methodologic pitfalls.
Demidova I; Barinov A; Savelov N; Gagarin I; Grinevitch V; Stroiakovaski D; Popov M; Laktionov K; Gutorov S; Smolin A; Olshanskaya Y; Obukhova T
Arch Pathol Lab Med; 2014 Jun; 138(6):794-802. PubMed ID: 24878018
[TBL] [Abstract][Full Text] [Related]
22. Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases.
Li XQ; Hisaoka M; Shi DR; Zhu XZ; Hashimoto H
Hum Pathol; 2004 Jun; 35(6):711-21. PubMed ID: 15188137
[TBL] [Abstract][Full Text] [Related]
23. Too Sensitive or Just Right?
Martin D; Smith SC; Chesney A; Jackson-Cook C; Pillappa R
Am J Clin Pathol; 2022 Aug; 158(2):283-290. PubMed ID: 35482487
[TBL] [Abstract][Full Text] [Related]
24. French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas.
Lantuejoul S; Rouquette I; Blons H; Le Stang N; Ilie M; Begueret H; Grégoire V; Hofman P; Gros A; Garcia S; Monhoven N; Devouassoux-Shisheboran M; Mansuet-Lupo A; Thivolet F; Antoine M; Vignaud JM; Penault-Llorca F; Galateau-Sallé F; McLeer-Florin A
Eur Respir J; 2015 Jul; 46(1):207-18. PubMed ID: 25929957
[TBL] [Abstract][Full Text] [Related]
25. Canadian anaplastic lymphoma kinase study: a model for multicenter standardization and optimization of ALK testing in lung cancer.
Cutz JC; Craddock KJ; Torlakovic E; Brandao G; Carter RF; Bigras G; Deschenes J; Izevbaye I; Xu Z; Greer W; Yatabe Y; Ionescu D; Karsan A; Jung S; Fraser RS; Blumenkrantz M; Lavoie J; Fortin F; Bojarski A; Côté GB; van den Berghe JA; Rashid-Kolvear F; Trotter M; Sekhon HS; Albadine R; Tran-Thanh D; Gorska I; Knoll JH; Xu J; Blencowe B; Iafrate AJ; Hwang DM; Pintilie M; Gaspo R; Couture C; Tsao MS
J Thorac Oncol; 2014 Sep; 9(9):1255-63. PubMed ID: 25122422
[TBL] [Abstract][Full Text] [Related]
26. Kinase expression in angiomatoid fibrous histiocytoma: panTRK is commonly expressed in the absence of
Vargas AC; Joy C; Maclean FM; Bonar F; Wong DD; Gill AJ; Cheah AL
J Clin Pathol; 2024 Mar; 77(4):251-254. PubMed ID: 38053271
[TBL] [Abstract][Full Text] [Related]
27. ALK-rearranged Tumors Are Highly Enriched in the STUMP Subcategory of Uterine Tumors.
Devereaux KA; Kunder CA; Longacre TA
Am J Surg Pathol; 2019 Jan; 43(1):64-74. PubMed ID: 29794871
[TBL] [Abstract][Full Text] [Related]
28. Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization.
Paik JH; Choe G; Kim H; Choe JY; Lee HJ; Lee CT; Lee JS; Jheon S; Chung JH
J Thorac Oncol; 2011 Mar; 6(3):466-72. PubMed ID: 21258247
[TBL] [Abstract][Full Text] [Related]
29. Uterine Inflammatory Myofibroblastic Tumor Showing an Atypical ALK Signal Pattern by FISH and DES-ALK Fusion by RNA Sequencing: A Case Report.
Zarei S; Abdul-Karim FW; Chase DM; Astbury C; Policarpio-Nicolas MLC
Int J Gynecol Pathol; 2020 Mar; 39(2):152-156. PubMed ID: 30741845
[TBL] [Abstract][Full Text] [Related]
30. Angiomatoid fibrous histiocytoma: comparison of fluorescence in situ hybridization and reverse transcription polymerase chain reaction as adjunct diagnostic modalities.
Thway K; Gonzalez D; Wren D; Dainton M; Swansbury J; Fisher C
Ann Diagn Pathol; 2015 Jun; 19(3):137-42. PubMed ID: 25804255
[TBL] [Abstract][Full Text] [Related]
31. Comparison of methods in the detection of ALK and ROS1 rearrangements in lung cancer.
Rogers TM; Russell PA; Wright G; Wainer Z; Pang JM; Henricksen LA; Singh S; Stanislaw S; Grille J; Roberts E; Solomon B; Fox SB
J Thorac Oncol; 2015 Apr; 10(4):611-8. PubMed ID: 25789833
[TBL] [Abstract][Full Text] [Related]
32. Antibody 1A4 with routine immunohistochemistry demonstrates high sensitivity for ALK rearrangement screening of Chinese lung adenocarcinoma patients: A single-center large-scale study.
Wang Q; Zhao L; Yang X; Wei S; Zeng Y; Mao C; Lin L; Fu P; Lyu L; Li Z; Xiao H
Lung Cancer; 2016 May; 95():39-43. PubMed ID: 27040850
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemistry as a screening tool for ALK rearrangement in NSCLC: evaluation of five different ALK antibody clones and ALK FISH.
Hutarew G; Hauser-Kronberger C; Strasser F; Llenos IC; Dietze O
Histopathology; 2014 Sep; 65(3):398-407. PubMed ID: 24612196
[TBL] [Abstract][Full Text] [Related]
34. ALK+ lung adenocarcinoma in never smokers and long-term ex-smokers: prevalence and detection by immunohistochemistry and fluorescence in situ hybridization.
Williams AS; Greer W; Bethune D; Craddock KJ; Flowerdew G; Xu Z
Virchows Arch; 2016 Nov; 469(5):533-540. PubMed ID: 27562706
[TBL] [Abstract][Full Text] [Related]
35. Cytology specimens offer an effective alternative to formalin-fixed tissue as demonstrated by novel automated detection for ALK break-apart FISH testing and immunohistochemistry in lung adenocarcinoma.
Rosenblum F; Hutchinson LM; Garver J; Woda B; Cosar E; Kurian EM
Cancer Cytopathol; 2014 Nov; 122(11):810-21. PubMed ID: 25099128
[TBL] [Abstract][Full Text] [Related]
36. [Identification of an optimal algorithm for effective diagnostics of non-small cell lung cancer with ALK gene rearrangement - implementation of the method and practical experiences with routine diagnostics].
Rozkoš T; Ryška A; Nová M; Hornychová H; Krbal L; Matěj R; Laco J
Cesk Patol; 2017; 53(2):89-96. PubMed ID: 28597670
[TBL] [Abstract][Full Text] [Related]
37. Optimized immunohistochemistry using the D5F3 antibody provides a reliable test for identification of ALK-positive lung adenocarcinomas.
Vinciguerra GLR; Scarpino S; Pini B; Cippitelli C; Fochetti F; Ruco L
Virchows Arch; 2017 Jul; 471(1):123-127. PubMed ID: 28516197
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of immunohistochemistry using two different antibodies and procedures for primary lung adenocarcinoma harboring anaplastic lymphoma kinase rearrangement.
Akiba J; Kawahara A; Abe H; Azuma K; Yamaguchi T; Taira T; Fukumitsu C; Takase Y; Yasumoto M; Umeno Y; Todoroki K; Kurita T; Yamaguchi R; Kage M; Yano H
Oncol Lett; 2014 Nov; 8(5):2155-2159. PubMed ID: 25295103
[TBL] [Abstract][Full Text] [Related]
39. Fluorescence in Situ Hybridization (FISH) for Detecting Anaplastic Lymphoma Kinase (
Tang Z; Wang L; Tang G; Medeiros LJ
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412611
[TBL] [Abstract][Full Text] [Related]
40. Improving Selection Criteria for ALK Inhibitor Therapy in Non-Small Cell Lung Cancer: A Pooled-Data Analysis on Diagnostic Operating Characteristics of Immunohistochemistry.
Jiang L; Yang H; He P; Liang W; Zhang J; Li J; Liu Y; He J
Am J Surg Pathol; 2016 May; 40(5):697-703. PubMed ID: 26825369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
